HIV infection and tuberculosis in South Africa -- an urgent need to escalate the public health response

August 24, 2009

The third paper documents SA's struggle with HIV/AIDS, with the chilling statistic that despite having just 0.7% of the world's population, the country has 17% of the global HIV burden. The paper is written by Professor Salim S Abdool Karim, CAPRISA (The Centre for the AIDS Programme of Research in South Africa), University of KwaZulu-Natal, SA, and colleagues.

SA also has one of the worst tuberculosis (TB) epidemics, made worse by rising drug resistance and HIV co-infection. The authors say: "Nonetheless, there have been notable achievements in disease management, including substantial improvements in access to condoms, expansion of tuberculosis control efforts, and scale-up of free antiretroviral therapy (ART). Care for acutely ill AIDS patients and long-term provision of ART are two issues that dominate medical practice and the health-care system. Decisive action is needed to implement evidence-based priorities for the control of the HIV and tuberculosis epidemics. Until recently, the South African Government's response to these diseases has been marked by denial, lack of political will, and poor implementation of policies and programmes."

The authors detail the priority actions needed to control tuberculosis, including improving the cure rate (which is inconsistent nationwide); improve detection rates, integrating tuberculosis and HIV services, and identifying and treating drug resistant TB. To achieve HIV prevention, the priority areas for action are understanding the main drivers and risk factors for HIV locally and nationally; scaling-up of behavioural, prevention of mother-to-child transmission, and HIV testing interventions; implementing male circumcision, and legislative interventions on sex work, gender violence, and migrant labour. The authors also give their priority actions for HIV treatment--scale-up HIV testing, initiate HIV ART treatment in all patients with a CD4-cell count below 350 cells per uL; maintain viral suppression in patients on ART; and integrate HIV prevention and treatment services. The authors say that for these plans to be implemented 'as part of the aspirational 5-year Strategic Plans for SA will depend on the government's ability to build partnerships and to stimulate the development of health-care services. This is a complex task which will need a long-term perspective, with the prospect of many difficult and, perhaps, unpopular decisions'.

They conclude: "South Africa still awaits the opportunity to enjoy its newfound political freedoms without the overhanging threat of the HIV and tuberculosis epidemics."
Professor Salim S. Abdool Karim, Pro Vice-Chancellor (Research), University of KwaZulu-Natal and Director: CAPRISA - Centre for the AIDS Programme of Research in South Africa T) +27-31-2604550 E)

Full paper 3:


Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to